Test Description
The Aspergillus Galactomanan test detects the presence of galactomannan, a polysaccharide component of the cell wall of Aspergillus species, in bronchoalveolar lavage (BAL) fluid.
This test is crucial for diagnosing invasive pulmonary aspergillosis (IPA), particularly in immunocompromised patients.
A positive result supports the diagnosis of IPA, while a negative result does not rule it out, necessitating further monitoring.
Indications of the Aspergillus Galactomanan Test
The Aspergillus Galactomanan test is indicated for:
- Diagnosis of invasive pulmonary aspergillosis: Particularly in patients with symptoms consistent with fungal infections and risk factors such as immunosuppression.
- Monitoring response to antifungal therapy: Changes in galactomannan levels can indicate the effectiveness of treatment.
Patient Preparation/Instructions
Patients undergoing this test should:
- Consult with their healthcare provider: To understand the implications and preparation needed for bronchoscopy.
- Avoid antifungal therapy prior to testing, if possible, as this may affect the sensitivity of the test.
Typical Reference Values
- Positive Result: Indicates potential invasive pulmonary aspergillosis.
- Negative Result: Does not exclude the diagnosis; further testing may be needed.
Turnaround Time
The results of the Aspergillus Galactomanan test are typically available within 1 day upon receipt at the reference laboratory.
How To Order This Test In Kenya
To order the Aspergillus Galactomanan test, please click the ‘Order Test’ button and add it to your cart.
